ID   ATG4B_HUMAN             Reviewed;         393 AA.
AC   Q9Y4P1; B7WNK2; Q53NU4; Q6ZUV8; Q8WYM9; Q96K07; Q96K96; Q96SZ1; Q9Y2F2;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-APR-2021, entry version 187.
DE   RecName: Full=Cysteine protease ATG4B;
DE            EC=3.4.22.-;
DE   AltName: Full=AUT-like 1 cysteine endopeptidase;
DE   AltName: Full=Autophagin-1;
DE   AltName: Full=Autophagy-related cysteine endopeptidase 1;
DE   AltName: Full=Autophagy-related protein 4 homolog B;
DE            Short=hAPG4B;
GN   Name=ATG4B; Synonyms=APG4B, AUTL1, KIAA0943;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   GLN-354.
RC   TISSUE=Liver;
RX   PubMed=12446702; DOI=10.1074/jbc.m208247200;
RA   Marino G., Uria J.A., Puente X.S., Quesada V., Bordallo J., Lopez-Otin C.;
RT   "Human autophagins, a family of cysteine proteinases potentially implicated
RT   in cell degradation by autophagy.";
RL   J. Biol. Chem. 278:3671-3678(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, FUNCTION IN
RP   GABARAPL2; GABARAP AND MAP1LC3A CLEAVAGE, ACTIVE SITE, MUTAGENESIS OF
RP   CYS-74, AND VARIANT GLN-354.
RX   PubMed=15169837; DOI=10.1242/jcs.01131;
RA   Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y.,
RA   Yoshimori T.;
RT   "LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on
RT   form-II formation.";
RL   J. Cell Sci. 117:2805-2812(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-354.
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 6).
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-354.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-354.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-12; 33-49; 120-137; 185-201 AND 230-244, ACETYLATION
RP   AT MET-1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [10]
RP   FUNCTION, ACTIVE SITE, AND MUTAGENESIS OF CYS-74.
RX   PubMed=15187094; DOI=10.1074/jbc.m401461200;
RA   Tanida I., Sou Y.-S., Ezaki J., Minematsu-Ikeguchi N., Ueno T.,
RA   Kominami E.;
RT   "HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human
RT   Atg8 homologues and delipidates microtubule-associated protein light chain
RT   3- and GABAA receptor-associated protein-phospholipid conjugates.";
RL   J. Biol. Chem. 279:36268-36276(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   FUNCTION, ACTIVITY REGULATION, AND MUTAGENESIS OF CYS-78.
RX   PubMed=17347651; DOI=10.1038/sj.emboj.7601623;
RA   Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., Elazar Z.;
RT   "Reactive oxygen species are essential for autophagy and specifically
RT   regulate the activity of Atg4.";
RL   EMBO J. 26:1749-1760(2007).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=21177865; DOI=10.1074/jbc.m110.199059;
RA   Li M., Hou Y., Wang J., Chen X., Shao Z.M., Yin X.M.;
RT   "Kinetics comparisons of mammalian Atg4 homologues indicate selective
RT   preferences toward diverse Atg8 substrates.";
RL   J. Biol. Chem. 286:7327-7338(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22302004; DOI=10.4161/auto.18777;
RA   Li M., Chen X., Ye Q.Z., Vogt A., Yin X.M.;
RT   "A high-throughput FRET-based assay for determination of Atg4 activity.";
RL   Autophagy 8:401-412(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS), ACTIVE SITE, AND MUTAGENESIS OF
RP   CYS-74; TRP-142; ARG-229; ASP-278 AND HIS-280.
RX   PubMed=16183633; DOI=10.1074/jbc.m509158200;
RA   Sugawara K., Suzuki N.N., Fujioka Y., Mizushima N., Ohsumi Y., Inagaki F.;
RT   "Structural basis for the specificity and catalysis of human Atg4B
RT   responsible for mammalian autophagy.";
RL   J. Biol. Chem. 280:40058-40065(2005).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), ACTIVE SITE, AND MUTAGENESIS OF
RP   CYS-74; ASP-278 AND HIS-280.
RX   PubMed=16325851; DOI=10.1016/j.jmb.2005.11.018;
RA   Kumanomidou T., Mizushima T., Komatsu M., Suzuki A., Tanida I., Sou Y.-S.,
RA   Ueno T., Kominami E., Tanaka K., Yamane T.;
RT   "The crystal structure of human Atg4b, a processing and de-conjugating
RT   enzyme for autophagosome-forming modifiers.";
RL   J. Mol. Biol. 355:612-618(2006).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-353 IN COMPLEX WITH RAT
RP   MAP1LC3B/LC3, AND FUNCTION.
RX   PubMed=19322194; DOI=10.1038/emboj.2009.80;
RA   Satoo K., Noda N.N., Kumeta H., Fujioka Y., Mizushima N., Ohsumi Y.,
RA   Inagaki F.;
RT   "The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing
RT   and delipidation during autophagy.";
RL   EMBO J. 28:1341-1350(2009).
CC   -!- FUNCTION: Cysteine protease required for the cytoplasm to vacuole
CC       transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of
CC       ATG8 family proteins MAP1LC3, GABARAPL1, GABARAPL2 and GABARAP, to
CC       reveal a C-terminal glycine. Exposure of the glycine at the C-terminus
CC       is essential for ATG8 proteins conjugation to phosphatidylethanolamine
CC       (PE) and insertion to membranes, which is necessary for autophagy. Has
CC       also an activity of delipidating enzyme for the PE-conjugated forms.
CC       {ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:15187094,
CC       ECO:0000269|PubMed:17347651, ECO:0000269|PubMed:19322194,
CC       ECO:0000269|PubMed:21177865, ECO:0000269|PubMed:22302004}.
CC   -!- ACTIVITY REGULATION: Inhibited by N-ethylmaleimide. Redox-regulated
CC       during autophagy since reducing conditions activate ATG4A whereas an
CC       oxidizing environment such as the presence of H(2)O(2) inhibits its
CC       activity. {ECO:0000269|PubMed:17347651}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.1 uM for MAP1LC3B {ECO:0000269|PubMed:21177865,
CC         ECO:0000269|PubMed:22302004};
CC         KM=5.8 uM for GABARAP {ECO:0000269|PubMed:21177865,
CC         ECO:0000269|PubMed:22302004};
CC         KM=4.4 uM for GABARAPL1 {ECO:0000269|PubMed:21177865,
CC         ECO:0000269|PubMed:22302004};
CC         KM=6.1 uM for GABARAPL2 {ECO:0000269|PubMed:21177865,
CC         ECO:0000269|PubMed:22302004};
CC   -!- INTERACTION:
CC       Q9Y4P1; O95166: GABARAP; NbExp=8; IntAct=EBI-712014, EBI-712001;
CC       Q9Y4P1; Q9H0R8: GABARAPL1; NbExp=10; IntAct=EBI-712014, EBI-746969;
CC       Q9Y4P1; P60520: GABARAPL2; NbExp=10; IntAct=EBI-712014, EBI-720116;
CC       Q9Y4P1; Q9H492: MAP1LC3A; NbExp=6; IntAct=EBI-712014, EBI-720768;
CC       Q9Y4P1; Q9GZQ8: MAP1LC3B; NbExp=14; IntAct=EBI-712014, EBI-373144;
CC       Q9Y4P1; Q9BXW4: MAP1LC3C; NbExp=4; IntAct=EBI-712014, EBI-2603996;
CC       Q9Y4P1; A0A0H3LAC5: ERDMAN_2289; Xeno; NbExp=2; IntAct=EBI-712014, EBI-25401874;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9Y4P1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4P1-2; Sequence=VSP_013029, VSP_013034;
CC       Name=3;
CC         IsoId=Q9Y4P1-3; Sequence=VSP_013028, VSP_013031, VSP_013032;
CC       Name=4;
CC         IsoId=Q9Y4P1-4; Sequence=VSP_013028, VSP_013033;
CC       Name=6;
CC         IsoId=Q9Y4P1-6; Sequence=VSP_013034;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in the skeletal muscle, followed
CC       by brain, heart, liver and pancreas. {ECO:0000269|PubMed:12446702,
CC       ECO:0000269|PubMed:15169837}.
CC   -!- SIMILARITY: Belongs to the peptidase C54 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76787.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC86110.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ504652; CAD43219.1; -; mRNA.
DR   EMBL; AB066215; BAB83890.1; -; mRNA.
DR   EMBL; AB023160; BAA76787.2; ALT_INIT; mRNA.
DR   EMBL; AK027332; BAB55042.1; -; mRNA.
DR   EMBL; AK027462; BAB55127.1; -; mRNA.
DR   EMBL; AK027763; BAB55353.1; -; mRNA.
DR   EMBL; AK125277; BAC86110.1; ALT_INIT; mRNA.
DR   EMBL; AL080168; CAB45756.1; -; mRNA.
DR   EMBL; AC133528; AAY14919.1; -; Genomic_DNA.
DR   EMBL; BC000719; AAH00719.1; -; mRNA.
DR   CCDS; CCDS46564.1; -. [Q9Y4P1-1]
DR   CCDS; CCDS46565.1; -. [Q9Y4P1-6]
DR   PIR; T12492; T12492.
DR   RefSeq; NP_037457.3; NM_013325.4. [Q9Y4P1-1]
DR   RefSeq; NP_847896.1; NM_178326.2. [Q9Y4P1-6]
DR   PDB; 2CY7; X-ray; 1.90 A; A=1-393.
DR   PDB; 2D1I; X-ray; 2.00 A; A/B=1-393.
DR   PDB; 2Z0D; X-ray; 1.90 A; A=1-353.
DR   PDB; 2Z0E; X-ray; 1.90 A; A=1-353.
DR   PDB; 2ZZP; X-ray; 2.05 A; A=1-353.
DR   PDB; 5LXH; X-ray; 1.58 A; E/F/G=384-393.
DR   PDB; 5LXI; X-ray; 1.44 A; C/E=384-393.
DR   PDBsum; 2CY7; -.
DR   PDBsum; 2D1I; -.
DR   PDBsum; 2Z0D; -.
DR   PDBsum; 2Z0E; -.
DR   PDBsum; 2ZZP; -.
DR   PDBsum; 5LXH; -.
DR   PDBsum; 5LXI; -.
DR   SMR; Q9Y4P1; -.
DR   BioGRID; 116801; 36.
DR   IntAct; Q9Y4P1; 23.
DR   MINT; Q9Y4P1; -.
DR   STRING; 9606.ENSP00000384259; -.
DR   BindingDB; Q9Y4P1; -.
DR   ChEMBL; CHEMBL1741221; -.
DR   MEROPS; C54.003; -.
DR   TCDB; 9.A.15.2.1; the autophagy-related phagophore-formation transporter (apt) family.
DR   iPTMnet; Q9Y4P1; -.
DR   PhosphoSitePlus; Q9Y4P1; -.
DR   BioMuta; ATG4B; -.
DR   DMDM; 296434400; -.
DR   EPD; Q9Y4P1; -.
DR   jPOST; Q9Y4P1; -.
DR   MassIVE; Q9Y4P1; -.
DR   PaxDb; Q9Y4P1; -.
DR   PeptideAtlas; Q9Y4P1; -.
DR   PRIDE; Q9Y4P1; -.
DR   ProteomicsDB; 86230; -. [Q9Y4P1-1]
DR   ProteomicsDB; 86231; -. [Q9Y4P1-2]
DR   ProteomicsDB; 86232; -. [Q9Y4P1-3]
DR   ProteomicsDB; 86233; -. [Q9Y4P1-4]
DR   ProteomicsDB; 86234; -. [Q9Y4P1-6]
DR   Antibodypedia; 12105; 700 antibodies.
DR   DNASU; 23192; -.
DR   Ensembl; ENST00000402096; ENSP00000384661; ENSG00000168397. [Q9Y4P1-4]
DR   Ensembl; ENST00000404914; ENSP00000384259; ENSG00000168397. [Q9Y4P1-1]
DR   Ensembl; ENST00000405546; ENSP00000383964; ENSG00000168397. [Q9Y4P1-6]
DR   GeneID; 23192; -.
DR   KEGG; hsa:23192; -.
DR   UCSC; uc002wbv.4; human. [Q9Y4P1-1]
DR   CTD; 23192; -.
DR   DisGeNET; 23192; -.
DR   GeneCards; ATG4B; -.
DR   HGNC; HGNC:20790; ATG4B.
DR   HPA; ENSG00000168397; Low tissue specificity.
DR   MIM; 611338; gene.
DR   neXtProt; NX_Q9Y4P1; -.
DR   OpenTargets; ENSG00000168397; -.
DR   PharmGKB; PA134898340; -.
DR   VEuPathDB; HostDB:ENSG00000168397.16; -.
DR   eggNOG; KOG2674; Eukaryota.
DR   GeneTree; ENSGT00530000063000; -.
DR   HOGENOM; CLU_021259_0_1_1; -.
DR   InParanoid; Q9Y4P1; -.
DR   OMA; RAPYSIH; -.
DR   OrthoDB; 431748at2759; -.
DR   PhylomeDB; Q9Y4P1; -.
DR   TreeFam; TF314847; -.
DR   PathwayCommons; Q9Y4P1; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   SIGNOR; Q9Y4P1; -.
DR   BioGRID-ORCS; 23192; 9 hits in 1005 CRISPR screens.
DR   ChiTaRS; ATG4B; human.
DR   EvolutionaryTrace; Q9Y4P1; -.
DR   GeneWiki; ATG4B; -.
DR   GenomeRNAi; 23192; -.
DR   Pharos; Q9Y4P1; Tbio.
DR   PRO; PR:Q9Y4P1; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9Y4P1; protein.
DR   Bgee; ENSG00000168397; Expressed in left lobe of thyroid gland and 236 other tissues.
DR   ExpressionAtlas; Q9Y4P1; baseline and differential.
DR   Genevisible; Q9Y4P1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0004175; F:endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0006914; P:autophagy; IDA:BHF-UCL.
DR   GO; GO:0016236; P:macroautophagy; TAS:Reactome.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl.
DR   GO; GO:0051697; P:protein delipidation; IDA:MGI.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   DisProt; DP01326; -.
DR   IDEAL; IID00347; -.
DR   InterPro; IPR032916; ATG4B_met.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR005078; Peptidase_C54.
DR   PANTHER; PTHR22624; PTHR22624; 1.
DR   PANTHER; PTHR22624:SF39; PTHR22624:SF39; 1.
DR   Pfam; PF03416; Peptidase_C54; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Autophagy; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Phosphoprotein; Protease;
KW   Protein transport; Reference proteome; Thiol protease; Transport;
KW   Ubl conjugation pathway.
FT   CHAIN           1..393
FT                   /note="Cysteine protease ATG4B"
FT                   /id="PRO_0000215844"
FT   ACT_SITE        74
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:15169837,
FT                   ECO:0000269|PubMed:15187094, ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   ACT_SITE        278
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   ACT_SITE        280
FT                   /evidence="ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         383
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..74
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013028"
FT   VAR_SEQ         1
FT                   /note="M -> MAHSVPSDSRTSRRPTTRPHAARGAPRGSRRPGRTPKWRLPRISARA
FT                   PYRLRRLRRHTYWPPRRPVAASRCWPVGATPLGSVGGRTGKM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013029"
FT   VAR_SEQ         321..354
FT                   /note="FFCKTEDDFNDWCQQVKKLSLLGGALPMFELVEL -> KQGRLVRSLIPWAP
FT                   RPSSWCAAVLGAAVVMCGTP (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013031"
FT   VAR_SEQ         355..393
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013032"
FT   VAR_SEQ         369
FT                   /note="L -> LGESCQVQVGSLG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013033"
FT   VAR_SEQ         370..393
FT                   /note="DSSDVERLERFFDSEDEDFEILSL -> GESCQVQILLM (in isoform
FT                   2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_013034"
FT   VARIANT         354
FT                   /note="L -> Q (in dbSNP:rs7601000)"
FT                   /evidence="ECO:0000269|PubMed:10231032,
FT                   ECO:0000269|PubMed:12446702, ECO:0000269|PubMed:15169837,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_021486"
FT   MUTAGEN         74
FT                   /note="C->S: Complete loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:15169837,
FT                   ECO:0000269|PubMed:15187094, ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   MUTAGEN         78
FT                   /note="C->A: Reduces the redox sensitivity and retains
FT                   activity in presence of H(2)O(2)."
FT                   /evidence="ECO:0000269|PubMed:17347651"
FT   MUTAGEN         142
FT                   /note="W->A: Strongly reduced protease activity."
FT                   /evidence="ECO:0000269|PubMed:16183633"
FT   MUTAGEN         229
FT                   /note="R->A: Strongly reduced protease activity."
FT                   /evidence="ECO:0000269|PubMed:16183633"
FT   MUTAGEN         278
FT                   /note="D->A: Complete loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   MUTAGEN         280
FT                   /note="H->A: Complete loss of protease activity."
FT                   /evidence="ECO:0000269|PubMed:16183633,
FT                   ECO:0000269|PubMed:16325851"
FT   CONFLICT        136
FT                   /note="Missing (in Ref. 2; BAB83890)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        188
FT                   /note="P -> L (in Ref. 5; BAB55127)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="F -> Y (in Ref. 5; BAB55353)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273
FT                   /note="E -> G (in Ref. 5; BAB55042)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="E -> N (in Ref. 2; BAB83890)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..7
FT                   /evidence="ECO:0007744|PDB:2Z0E"
FT   HELIX           10..13
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           14..18
FT                   /evidence="ECO:0007744|PDB:2Z0E"
FT   STRAND          22..24
FT                   /evidence="ECO:0007744|PDB:2D1I"
FT   STRAND          26..28
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          31..33
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   TURN            35..37
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           39..48
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          54..57
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   TURN            61..64
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   TURN            70..72
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           74..91
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          100..102
FT                   /evidence="ECO:0007744|PDB:2Z0E"
FT   HELIX           106..113
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          116..118
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           125..133
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   TURN            134..136
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           145..156
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   TURN            160..162
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          165..168
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          173..175
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           176..183
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          184..186
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          222..229
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          232..234
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           237..239
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           240..246
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          252..257
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          264..270
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          273..277
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          281..284
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          290..292
FT                   /evidence="ECO:0007744|PDB:2D1I"
FT   HELIX           297..299
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          306..309
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           310..312
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          315..325
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           326..341
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          349..353
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   HELIX           371..376
FT                   /evidence="ECO:0007744|PDB:2CY7"
FT   STRAND          388..390
FT                   /evidence="ECO:0007744|PDB:5LXH"
SQ   SEQUENCE   393 AA;  44294 MW;  F4ADB3192176E0E5 CRC64;
     MDAATLTYDT LRFAEFEDFP ETSEPVWILG RKYSIFTEKD EILSDVASRL WFTYRKNFPA
     IGGTGPTSDT GWGCMLRCGQ MIFAQALVCR HLGRDWRWTQ RKRQPDSYFS VLNAFIDRKD
     SYYSIHQIAQ MGVGEGKSIG QWYGPNTVAQ VLKKLAVFDT WSSLAVHIAM DNTVVMEEIR
     RLCRTSVPCA GATAFPADSD RHCNGFPAGA EVTNRPSPWR PLVLLIPLRL GLTDINEAYV
     ETLKHCFMMP QSLGVIGGKP NSAHYFIGYV GEELIYLDPH TTQPAVEPTD GCFIPDESFH
     CQHPPCRMSI AELDPSIAVG FFCKTEDDFN DWCQQVKKLS LLGGALPMFE LVELQPSHLA
     CPDVLNLSLD SSDVERLERF FDSEDEDFEI LSL
//
